• Blog
  • Artificial Tears Market Report

    Artificial Tears Market Report

    Artificial Tears Market Report
    Report code - SR1058 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Artificial Tears Market, Trends, Dynamics, Market analysis
    See more...

    Impact of COVID-19 on Artificial Tears Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Artificial Tears Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Artificial Tears Market is projected to grow from USD 2.6 billion in 2020 to USD 3.6 billion by 2026 at a CAGR of around 5.5% during the forecast period.

    Figure: Global Artificial Tears Market Size, 2020-2026 (USD Billion)

    Artificial-Tears-Market-Forecast

    Wish to get a full scope of this study? Click here

    What are Artificial Tears?

    Artificial tears are eye drops used to relieve dryness and irritation of the ocular surface by lubricating them. It retains moisture on the outer surface of the eyes. Artificial tears can be categorized as cellulose-derived tears, glycerine-derived tears, oil-based emulsion tears, polyethylene glycol-based tears, propylene glycol-based tears, and sodium hyaluronate-based artificial tears.

    Key Players

    Key players operating in the global Artificial Tears market are-

    • Johnson and Johnson Services, Inc. (The U.S),
    • Alcon Inc. (Switzerland),
    • OASIS Medical (The U.S),
    • AbbVie Inc. (The U.S),
    • Bayer AG (Germany),
    • Prestige Consumer Healthcare Inc. (The U.S),
    • Santen Pharmaceutical Co., Ltd. (Japan),
    • Bausch Health Companies Inc. (Canada),
    • Akorn Inc. (The U.S), and
    • Aurolab (India).

    Market Dynamics

    The growth of the global artificial tears market is primarily driven by an increasing number of people having eye-related health issues due to dryness and irritation. Prolonged exposure to digital displays, poor eyelids, chronic conjunctivitis, and malnutrition among others has resulted in increasing cases of dry eye syndrome (DES) is likely to propel the market growth at a significant rate during the review period. In addition to this, increasing demand for technological advancement in artificial tears is likely to create lucrative opportunities for the players operating in the global market in the coming years

    Segments' Analysis

    Delivery Mode Trends

    By delivery mode, the artificial tears market has been bifurcated into eye drops and ointments. The eye drops segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to high preference for drops over ointments among the consumers.

    Regional Trends

    By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period.

    • The regional growth can be attributed to expanding geriatric populace and the presence of key market players such as Johnson and Johnson Services, Inc. (US) and OASIS Medical (US).
    • The market in Asia-Pacific is expected to be driven by increased spending on healthcare coupled with rising per capita disposable income of the consumers particularly in China and India.

    COVID-19 Impact on Global Artificial Tears Market

    Covid-19 outbreak impacted the growth of the artificial tears market negatively. The spread of coronavirus led to the enforcement of lockdown to curb the spread of the virus. This led to travel restrictions and supply chain disruptions, which affected the product supply and demand.

    Critical Questions Answered in the Report

    • What are the key trends in the global Artificial Tears market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global Artificial Tears market?
    • What are the key strategies adopted by the major vendors to lead in the global Artificial Tears market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    The following is a list of the customers that the Artificial Tears market aims to convert the most:

    • Artificial tears distributors
    • Artificial tears suppliers
    • Artificial tears manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The artificial tears market size is expected to reach USD 3.6 billion in the foreseeable future.

    Johnson and Johnson Services, Inc. (The U.S), Alcon Inc. (Switzerland), OASIS Medical (The U.S), AbbVie Inc. (The U.S), Bayer AG (Germany), Prestige Consumer Healthcare Inc. (The U.S), Santen Pharmaceutical Co., Ltd. (Japan), Bausch Health Companies Inc. (Canada), Akorn Inc. (The U.S) and Aurolab (India) are among the key players in the artificial tears market.

    The artificial tears market is expected to witness an impressive growth of 5.5% CAGR in the coming years.

    North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR.

    The eye drops segment is expected to register significant growth in the artificial tears market in the coming years.

    Artificial tears distributors, Artificial tears suppliers, Artificial tears manufacturers, Logistics organizations, Government bodies are the target audience in the artificial tears market.

    •